Pengfei Shi

ORCID: 0000-0003-4297-5714
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Metal complexes synthesis and properties
  • Nonlinear Optical Materials Studies
  • Crystallography and molecular interactions
  • Porphyrin and Phthalocyanine Chemistry
  • Photochromic and Fluorescence Chemistry
  • Ferrocene Chemistry and Applications
  • Luminescence and Fluorescent Materials
  • Synthesis and Catalytic Reactions
  • Catalytic C–H Functionalization Methods
  • DNA and Nucleic Acid Chemistry
  • Nanoplatforms for cancer theranostics
  • Metabolism, Diabetes, and Cancer
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • Pancreatic and Hepatic Oncology Research
  • Advanced biosensing and bioanalysis techniques
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • Histone Deacetylase Inhibitors Research
  • Polyoxometalates: Synthesis and Applications
  • Asymmetric Hydrogenation and Catalysis
  • Virus-based gene therapy research
  • Photodynamic Therapy Research Studies

Hangzhou First People's Hospital
2024

Westlake University
2024

Huazhong University of Science and Technology
2011-2024

Central Hospital of Wuhan
2015-2024

Shanghai Ocean University
2019-2022

The Synergetic Innovation Center for Advanced Materials
2019

Nanjing Tech University
2019

Zhoukou City Academy of Agricultural Sciences
2019

Nanjing University
2006-2017

Collaborative Innovation Center of Advanced Microstructures
2017

Pancreatic cancer is the fourth leading cause of related deaths in United States. The prognosis remains dismal with little advance treatment. Metformin a drug widely used for treatment type II diabetes. Recent epidemiologic data revealed that oral administration metformin associated reduced risk pancreatic cancer, suggesting its potential as novel this disease. Many studies have demonstrated vitro anticancer action metformin, but typically concentrations were much higher than vivo plasma and...

10.1371/journal.pone.0063969 article EN cc-by PLoS ONE 2013-05-08

Cobaltacycle synthesis via C-H activation has been achieved for the first time, providing key mechanistic insight into cobalt catalytic chemistry. N-Chloroamides are used as a directing synthon cobalt-catalyzed room-temperature and construction of heterocycles. Alkynes coupling partners allow convenient access to isoquinolones, class synthetically pharmaceutically important compounds. The broad substrate scope enables diverse range substitution patterns be incorporated heterocyclic scaffold.

10.1021/acs.orglett.7b02632 article EN Organic Letters 2017-09-19

We report herein the development of a Co(III)-catalyzed enaminone-directed C–H amidation method for synthetic access to quinolones, an important heterocyclic scaffold diverse pharmaceutically active structures. The coupling with dioxazolones and subsequent deacylation installed amide group allow consecutive C–N generation quinolones wide-ranging compatible substituent patterns.

10.1021/acs.orglett.7b00968 article EN Organic Letters 2017-04-20

Abstract The prognosis of pancreatic cancer remains dismal, with little advance in chemotherapy because its high frequency chemoresistance. Metformin is widely used to treat type II diabetes and was shown recently inhibit stem cell proliferation. In the present study, we investigated role metformin chemoresistance cells gemcitabine possible cellular molecular mechanisms. increases sensitivity gemcitabine. mechanism involves, at least part, inhibition CD133 + proliferation suppression P70S6K...

10.1038/srep14404 article EN cc-by Scientific Reports 2015-09-22

At present, GPX4's role in the occurrence and development of diffuse large B lymphoma (DLBCL) is rarely reported. This study's purpose to explore significance diagnosis, treatment, pathological mechanisms DLBCL. The TIMER 2.0, GEPIA, GEO databases were used analyze expression levels DLBCL tissue, peripheral blood, single cells, evaluate its potential performance as a therapeutic diagnostic marker. Cell experiments validate cells. And revealed mechanism action from three aspects: immunity,...

10.1016/j.heliyon.2024.e24857 article EN cc-by Heliyon 2024-01-26

Pancreatic cancer is one of the most lethal malignancies with poor prognosis. Previously, we found that a subpopulation stem cells (CSCs) in Panc-1 pancreatic cell line could propagate to form spheres. Here characterized malignant phenotypes CD44+/CD24+ cells, which were enriched under sphere forming conditions as analyzed by flow cytometry. These demonstrated increased resistance gemcitabine and migration ability. Moreover, these exhibited epithelial mesenchymal transition decreased level...

10.3390/ijms12031595 article EN cc-by International Journal of Molecular Sciences 2011-03-01

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, is reported to exert anti-tumor effects by upregulating the expression of natural killer group 2D (NKG2D) ligands on tumor cells; however, mechanisms vary in different types, and effect mechanism action VPA pancreatic cancer cells are unknown. The present study evaluated susceptibility NK cell-mediated lysis vitro vivo. Then we investigated which depend on. lactate dehydrogenase assay (LDH) xenograft experiment demonstrated that...

10.1186/1471-2407-14-370 article EN cc-by BMC Cancer 2014-05-25

An efficient cobalt-catalyzed ring-opening reaction of bench-stable 1,2-oxazetidines with heteroarenes was unprecedentedly developed. The sustainable Cp*Co(III) catalyst enables a distinctive merger C–H activation concomitant N–O and C–C cleavages 1,2-oxazetidine, leading to site-selective aminomethylation hydroxymethylation heteroaromatic compounds containing broad range functional groups. Preliminary control experiments unravel some essential mechanistic features this one-pot transformation.

10.1021/acs.orglett.9b00141 article EN Organic Letters 2019-02-26

Multiphoton excitation allows one to access high energy excited states and perform valuable tasks in biological systems using tissue penetrating near-infrared (NIR) light. Here, we describe new photoactive manganese tricarbonyl complexes incorporating the ligand 4′-p-N,N-bis(2-hydroxyethyl)amino-benzyl-2,2′:6′,2″-terpyridine (TPYOH), which can serve as an antenna for two photon NIR excitation. Solutions of Mn(CO)3(TPYOH)X (X = Br– or CF3SO3–) are very toward CO release under visible light...

10.1021/acs.inorgchem.9b01581 article EN Inorganic Chemistry 2019-08-01

A C–H activation-based strategy has been developed for the synthesis of N-amino azaheterocycles. Rh(III)-catalyzed coupling N-Boc hydrazones/N-Boc hydrazines with diazodiesters/diazoketoesters provides convenient access to synthetically and medicinally important compounds, isoquinolin-3-ones indoles, by harnessing N-tert-butyloxycarbonyl (N-Boc) cleavage as an adaptable reactivity pattern in distinct synthetic scenarios.

10.1021/acs.orglett.7b02066 article EN Organic Letters 2017-08-04

Ruthenium-catalyzed heteroannulation between enamides and isocyanates has been realized as a complementary approach to conventional strategies for the synthesis of pyrimidin-4-ones. High step- atom-economy was achieved rapid construction such privileged scaffolds, which are found in multitude pharmaceutical compounds. The generality practicability this transformation were reflected by broad scope substrates with diverse functional groups, large-scale synthesis, late-stage diversification.

10.1039/c9cc03612a article EN Chemical Communications 2019-01-01

A trinuclear 3N-chelated monofunctional platinum complex, [Pt3(HPTAB)Cl3](ClO4)3 (HPTAB = N,N,N',N',N'',N''-hexakis(2-pyridylmethyl)-1,3,5-tris(aminomethyl)benzene), has been structurally characterized, which binds to DNA and demonstrates much higher potency against the murine leukemia cell line (P-388) human nonsmall-cell lung cancer (A-549) than cisplatin.

10.1039/b601739h article EN Dalton Transactions 2006-01-01

A mitochondrion-targeting Mn<sup>II</sup>-terpyridine complex (MTP) has been developed for providing a good spatial condition to generate <sup>1</sup>O<sub>2</sub>, which further promoted the two-photon photodynamic therapy (PDT) effect.

10.1039/d0cc02051f article EN Chemical Communications 2020-01-01

As the standard therapy for pancreatic cancer, gemcitabine shows limited efficacy in cancer patients because of chemoresistance. Aberrant expression Bmi1 has been reported to activate multiple growth-regulatory pathways and confer anti-apoptotic abilities many cells. However, role response cells towards resistance remains elusive. In this study, we found that certain dose treatment induced Knockdown enhanced ROS production promoted cytotoxic effect gemcitabine. The increased oxidative stress...

10.18632/oncotarget.9293 article EN Oncotarget 2016-05-11

The terpyridine and its Zn(<sc>ii</sc>) complex process large conjugation system suitable electron donors, so that they display strong two-photon excited fluorescence.

10.1039/c5dt00449g article EN Dalton Transactions 2015-01-01

Here we have designed and synthesized a novel analogous cis-platinum complex (TDPt) with strong two-photon absorption properties higher stability upon laser irradiation. Interestingly, cytotoxicity against three types of cancer cells compared to that commercial was observed. The initial confocal micrographs showed lysosomes may be the biological targets such TDPt, except conventional presumed DNA. This hypothesis further confirmed by microscopy transmission electron micrograph. These results...

10.1021/bi5014062 article EN Biochemistry 2015-02-04

Since the discovery of copper induces cell death(cuprotosis) in 2022, it has been one biggest research hotspots. cuprotosis related genes (CRGs) demonstrated to be a potential therapeutic target for cancer, however, molecular mechanism CRGs coronavirus disease 2019 (COVID-19) infected DLBCL patients not reported yet. Therefore, our objective is first elucidate and role COVID-19. Secondly, we conducted univariate multivariate analysis machine learning screen with common expression differences...

10.1007/s10495-024-01959-0 article EN cc-by APOPTOSIS 2024-04-06

Neratinib, a typical small-molecule, pan-human tyrosine kinase inhibitor (TKI), has been licensed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, underlying pharmacological mechanism is still unknown. In current study, we report novel function Neratinib by showing that its stimulates senescence mammary cancer AU565 cells. Our results demonstrate induces mitochondrial injury increasing reactive oxygen species (ROS) and reducing...

10.18632/aging.205882 article EN cc-by Aging 2024-05-31
Coming Soon ...